[1]
|
Rajkumar, S.V., Dimopoulos, M.A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.V., et al. (2014) International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma. Lancet Oncology, 15, e538-e548.
https://doi.org/10.1016/S1470-2045(14)70442-5
|
[2]
|
Kotlín, R., Sobotková, A., Riedel, T., et al. (2008) Acquired Dysfibrinogenemia Secondary to Multiple Myeloma. Acta Haematologica, 120, 75-81. https://doi.org/10.1159/000160182
|
[3]
|
Mosesson, M.W. (2010) Fibrinogen and Fibrin Structure and Functions. Journal of Thrombosis & Haemostasis, 3, 1894-1904. https://doi.org/10.1111/j.1538-7836.2005.01365.x
|
[4]
|
Casini, A., Neerman-Arbez, M., Ariëns, R.A., et al. (2015) Dysfibrinogenemia: From Molecular Anomalies to Clinical Manifestations and Management. Journal of Thrombosis and Haemostasis, 13, 909-919.
https://doi.org/10.1111/jth.12916
|
[5]
|
Regañón, E., Vila, V., Aznar, J., Garrido, G., Estellés, A. and Berenguer, J. (1987) Study of the Formation of Fibrin Clot in Cirrhotic Patients: An Approach to Study of Acquired Dysfibrinogenemia. Thrombosis Research, 46, 705-714.
https://doi.org/10.1016/0049-3848(87)90272-6
|
[6]
|
Moerloose, P.D., Casini, A. and Neerman-Arbez, M. (2013) Congenital Fibrinogen Disorders: An Update. Seminars in Thrombosis and Hemostasis, 39, 585-595. https://doi.org/10.1055/s-0033-1349222
|
[7]
|
Arai, S., Kamijo, T., Takezawa, Y., Sugano, M., Nakazawa, H., Yanagisawa, R., Uehara, T., Honda, T. and Okumura, N. (2020) Acquired Dysfibrinogenemia: Monoclonal λ-Type IgA Binding to Fibrinogen Caused Lower Functional Plasma Fibrinogen Level and Abnormal Clot Formation. International Journal of Hematology, 112, 96-104.
https://doi.org/10.1007/s12185-020-02874-1
|
[8]
|
Zitomersky, N.L., Menno, V. and Trenor, C.C. (2015) Thrombosis and Inflammatory Bowel Disease: A Call for Improved Awareness and Prevention. Inflammatory Bowel Diseases, 17, 458-470. https://doi.org/10.1002/ibd.21334
|
[9]
|
Mori, T., Murata, M., Wakui, M., Muto, A. and Ikeda, Y. (2010) Acquired Dysfibrinogenemia Following Allogeneic Bone Marrow Transplantation. American Journal of Hematology, 56, 294-295.
https://doi.org/10.1002/(SICI)1096-8652(199712)56:4<294::AID-AJH17>3.0.CO;2-9
|
[10]
|
孙扬杰, 马林, 方斐, 孙瑞文. 多发性骨髓瘤高纤维蛋白原血症1例报告并文献复习[J]. 基层医学论坛, 2012, 16(11): 1489-1490.
|
[11]
|
中国医师协会血液科医师分会, 中华医学会血液学分会, 中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2020年修订) [J]. 中华内科杂志, 2020, 59(5): 341-346.
|
[12]
|
Chu, T.T., Wang, H., Lv, X., Qi, J.Q., Tang, Y.Q., Fan, Y., et al. (2021) Investigation of Fibrinogen in Early Bleeding of Patients with Newly Diagnosed Acute Promyelocytic Leukemia. Platelets, 32, 677-683.
https://doi.org/10.1080/09537104.2020.1799969
|